Crinetics Pharmaceuticals (CRNX) Receivables (2017 - 2026)

Crinetics Pharmaceuticals' (CRNX) quarterly Receivables came in at $14.6 million in Q1 2026, up 75.33% quarter-over-quarter from $8.4 million in Q4 2025.

Crinetics Pharmaceuticals (CRNX) Receivables (2017 - 2026) Analysis & Trends

Crinetics Pharmaceuticals' Receivables history runs 6 years deep, the most recent figure standing at $14.6 million for Q1 2026.

  • On a quarterly basis, Receivables changed N/A year-over-year to $14.6 million in Q1 2026; TTM through Mar 2026 was $14.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at $8.4 million, changed 0.48% from the prior year.
  • Receivables improved to $14.6 million in Q1 2026 per CRNX's latest filing, from $8.4 million in the prior quarter.
  • Across five years, Receivables topped out at $14.6 million in Q1 2026 and bottomed at $8.3 million in Q4 2024.
  • The 3-year median for Receivables is $8.4 million (2025), against an average of $10.4 million.
  • Biggest YoY gain for Receivables was 0.48% in 2025; the steepest drop was 0.48% in 2025.
  • Year by year, Receivables stood at $8.3 million in 2024, then increased by 0.48% to $8.4 million in 2025, then jumped by 75.33% to $14.6 million in 2026.
  • Per Business Quant, the three latest CRNX Receivables figures stand at $14.6 million (Q1 2026), $8.4 million (Q4 2025), and $8.3 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 4.97 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 938.02 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.13 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.00 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.73 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.93 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Crinetics Pharmaceuticals 8.71 Bn 8.71 Bn 10.53 Mn 14.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.64 Mn
Dec 31, 2025 8.35 Mn
Dec 31, 2024 8.31 Mn
Dec 31, 2019 449,000.00
Sep 30, 2019 474,000.00
Mar 31, 2019 796,000.00
Dec 31, 2018 908,000.00
Sep 30, 2018 510,000.00
Jun 30, 2018 657,000.00
Dec 31, 2017 231,000.00